News | January 09, 2015

CHI Franciscan Health Designated As The First Northwest Accredited Heart Failure System

Healthcare Colloquium was chosen as accreditation body because of framework that enables standardized best practices and coordination of care

heart Failure, CHI Franciscan, Healthcare Colloquium

Image courtesy of PR Newswire

January 9, 2015 — The Healthcare Colloquium announced that CHI Franciscan Health is the first Accredited Heart Failure System in the Northwest.

St. Joseph Medical Center earned recognition as an Accredited Heart Failure Institute.

St. Elizabeth Hospital, St. Francis Hospital, St. Clare Hospital, St. Anthony Hospital and Harrison Medical Center became Accredited Heart Failure Centers.  CHI Franciscan Health is the third Accredited Heart Failure system through The Healthcare Colloquium.

The Healthcare Colloquium's unique heart failure accreditation process builds on the member hospital's prior improvement experience leading to initial heart failure accreditation. Member hospitals work within four established domains of heart failure: community, hospital, clinicians and science using The Healthcare Colloquium's continuum of care model that leads to:  

·  Integration of heart failure care; from antecedents to early diagnosis and advanced care

·  Streamlined processes across the entire continuum of care beginning in the community

·  Enabling individuals to participate in their own care with more independence and less hospitalization

·  Collaboration with other Colloquium member hospitals across the country

For more information:

Related Content

MyoKardia Presents Additional Positive Data From Phase 2 PIONEER-HCM Study at HFSA 2017
News | Heart Failure| September 21, 2017
MyoKardia Inc. announced that additional positive data from the first patient cohort of its Phase 2 PIONEER-HCM study...
Heart Failure Market to Surpass $16 Billion by 2026
News | Heart Failure| September 19, 2017
The heart failure space across the seven key markets of the U.S., France, Germany, Italy, Spain, the U.K. and Japan is...
Heart Failure Patients, Clinicians Have Differing Perceptions of Risk Level
News | Heart Failure| September 06, 2017
September 6, 2017 — Physicians identified a majority of patients with advanced...
Israeli Hospital Completes First Implant of CORolla Heart Failure Device
News | Heart Failure| September 05, 2017
Rambam Hospital in Haifa, Israel, recently became the first to use the CORolla device from Israeli start-up company...
Abbott Receives FDA Approval for HeartMate 3 Left Ventricular Assist System
Technology | Ventricular Assist Devices (VAD)| August 29, 2017
Abbott announced it has received U.S. Food and Drug Administration (FDA) approval for its Full MagLev HeartMate 3 Left...
Sponsored Content | Videos | Cardiovascular Ultrasound| August 28, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
Registry Identifies Early Onset of Heart Failure and Lack of Defibrillators in Asia
News | Heart Failure| August 03, 2017
August 3, 2017 — The Asian Pacific Society of Cardiology (ASPC) held its first-ever late-breaking...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Overlay Init